
Japan on the Move
By Fintan Walton
Pharma Deals Review: Vol 2009 Issue 5 (Table of Contents)
Published: 15 May-2009
DOI: 10.3833/pdr.v2009.i5.1108 ISSN: 1756-7874
Section: Business Commentaries
Fulltext:
Abstract
Japanese pharmaceutical companies are facing a changing healthcare landscape in their domestic markets and are continuing to look for overseas acquisitions for sustained growth. With a reluctance to pay over the odds for acquisitions in the short-term, will Japanese companies pay for it in the long-term.
Copyright: © IQVIA 2018